Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01850706 · ClinicalTrials.gov registry record
UNGF Assessment in Patients With Detrusor Overactivity Undergoing Sacral Neuromodulation
A clinical trial, sponsored by Northwell Health.
- Completed
- Registry status
- 50
- Enrollment target
NCT01850706: Completed study, sponsored by Northwell Health.
NCT01850706 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01850706 has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to find a noninvasive test to help physicians diagnose detrusor overactivity (DO), to use this urine test to help diagnose bladder problems, determine if treatments are working, and determine if patients are good candidates for interventions like sacral neuromodulation/Interstim Therapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2011-08 |
| Est. Completion | 2016-03 |
What the finished NCT01850706 record still lists
NCT01850706 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01850706 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01850706 about?
NCT01850706 is a clinical study titled "UNGF Assessment in Patients With Detrusor Overactivity Undergoing Sacral Neuromodulation". The purpose of this study is to find a noninvasive test to help physicians diagnose detrusor overactivity (DO), to use this urine test to help diagnose bladder problems, determine if treatments are working, and determine if patients are good candidates for interventions like sacral neuromodulation/I...
What is the current status of trial NCT01850706?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2011-08. Estimated completion is 2016-03.
Who is sponsoring clinical trial NCT01850706?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia